JP2022516945A5 - - Google Patents

Info

Publication number
JP2022516945A5
JP2022516945A5 JP2021539571A JP2021539571A JP2022516945A5 JP 2022516945 A5 JP2022516945 A5 JP 2022516945A5 JP 2021539571 A JP2021539571 A JP 2021539571A JP 2021539571 A JP2021539571 A JP 2021539571A JP 2022516945 A5 JP2022516945 A5 JP 2022516945A5
Authority
JP
Japan
Prior art keywords
patent document
administration
international publication
therapeutic agents
international
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021539571A
Other languages
English (en)
Japanese (ja)
Other versions
JP7465271B2 (ja
JP2022516945A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/012552 external-priority patent/WO2020146362A1/en
Publication of JP2022516945A publication Critical patent/JP2022516945A/ja
Publication of JP2022516945A5 publication Critical patent/JP2022516945A5/ja
Application granted granted Critical
Publication of JP7465271B2 publication Critical patent/JP7465271B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021539571A 2019-01-09 2020-01-07 治療剤放出のための眼球装着装置 Active JP7465271B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962790313P 2019-01-09 2019-01-09
US62/790,313 2019-01-09
PCT/US2020/012552 WO2020146362A1 (en) 2019-01-09 2020-01-07 Eye mounted device for therapeutic agent release

Publications (3)

Publication Number Publication Date
JP2022516945A JP2022516945A (ja) 2022-03-03
JP2022516945A5 true JP2022516945A5 (https=) 2022-08-29
JP7465271B2 JP7465271B2 (ja) 2024-04-10

Family

ID=69400668

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021539571A Active JP7465271B2 (ja) 2019-01-09 2020-01-07 治療剤放出のための眼球装着装置

Country Status (9)

Country Link
US (2) US11399976B2 (https=)
EP (1) EP3908238B1 (https=)
JP (1) JP7465271B2 (https=)
KR (1) KR102650504B1 (https=)
CN (1) CN113784691A (https=)
BR (1) BR112021013455A2 (https=)
CA (1) CA3126135A1 (https=)
IL (1) IL284731B2 (https=)
WO (1) WO2020146362A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3908238B1 (en) 2019-01-09 2026-03-25 Verily Life Sciences LLC Eye mounted device for therapeutic agent release
WO2022026720A1 (en) * 2020-07-31 2022-02-03 Board Of Regents Of The University Of Nebraska Hydrogel ionic circuit based devices for electrical stimulation and drug therapy
WO2022061028A1 (en) * 2020-09-18 2022-03-24 The Regents Of The University Of California Micro-engineered poly(hema) hydrogel for wearable contact lens biosensing and other applications
WO2023076105A1 (en) * 2021-10-25 2023-05-04 Twenty Twenty Therapeutics Llc Fluid osmolarity sensing and associated systems, devices, and methods
US20230135281A1 (en) * 2021-10-28 2023-05-04 Twenty Twenty Therapeutics Llc Controlled release of a therapeutic from an ophthalmic device with a locally enhanced concentration of chloride ions
US12527691B2 (en) * 2021-11-05 2026-01-20 W. L. Gore & Associates, Inc. Fluid drainage devices, systems, and methods
US12544262B2 (en) * 2021-11-05 2026-02-10 W. L. Gore & Associates, Inc. Fluid drainage devices, systems, and methods
CN114870245A (zh) * 2022-04-15 2022-08-09 杭州宝尔科技有限公司 一种微电脑脉冲近视防治仪
CN114917072B (zh) * 2022-04-27 2026-02-10 南方科技大学 眼部递送装置及其制备方法
WO2023244692A1 (en) * 2022-06-14 2023-12-21 Twenty Twenty Therapeutics Llc Systems and methods for preventing or slowing the progression of myopia with a smart ophthalmic device
EP4646176A1 (en) 2023-01-04 2025-11-12 Verily Life Sciences LLC Dry eye treatment device
WO2024232885A1 (en) * 2023-05-10 2024-11-14 Twenty Twenty Therapeutics Creating a drug dispensing ophthalmic device with integrated modular elements
US12508156B2 (en) * 2023-05-12 2025-12-30 Verily Life Sciences Llc Achieving uniform patterned drug release via at least one embedded microchannel in an ophthalmic device
WO2025042765A1 (en) * 2023-08-22 2025-02-27 Verily Life Sciences Llc Active drug dispensing ophthalmic device having a controller-responder architecture
KR102883994B1 (ko) * 2023-09-25 2025-11-10 서강대학교산학협력단 항암 치료를 위한 이온토포레시스 경피 약물 전달 장치 및 시스템

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4014335A (en) * 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US5080646A (en) * 1988-10-03 1992-01-14 Alza Corporation Membrane for electrotransport transdermal drug delivery
JPH07185016A (ja) * 1993-09-01 1995-07-25 Makoto Haga イオントフォレシス用生体適用デバイス
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US6544193B2 (en) 1996-09-04 2003-04-08 Marcio Marc Abreu Noninvasive measurement of chemical substances
FR2773320B1 (fr) 1998-01-05 2000-03-03 Optisinvest Dispositif pour le transfert intraoculaire de produits actifs par iontophorese
US6319240B1 (en) * 1999-05-25 2001-11-20 Iomed, Inc. Methods and apparatus for ocular iontophoresis
US6579276B2 (en) * 2001-01-22 2003-06-17 Iomed, Inc. Ocular iontophoretic device and method for inhibiting vascular endothelial growth factor (VEGF) using the same
US7181287B2 (en) 2001-02-13 2007-02-20 Second Sight Medical Products, Inc. Implantable drug delivery device
US7349733B2 (en) * 2001-11-02 2008-03-25 Ceramatel, Inc. Iontophoretic drug delivery systems
DE60336727D1 (de) 2002-08-16 2011-05-26 Microchips Inc Vorrichtung mit kontrollierter abgabe und verfahren
FR2869531B1 (fr) * 2004-04-30 2006-07-14 Optis France Sa Sa Dispositif de iontophorese oculaire diminuant les irritations
EP1765455A2 (en) * 2004-06-01 2007-03-28 Microchips, Inc. Devices and methods for measuring and enhancing drug or analyte transport to/from medical implant
WO2006015299A2 (en) * 2004-07-30 2006-02-09 Microchips, Inc. Multi-reservoir device for transdermal drug delivery and sensing
US8246949B2 (en) * 2004-10-27 2012-08-21 Aciont, Inc. Methods and devices for sustained in-vivo release of an active agent
EP1827399A1 (en) * 2004-12-17 2007-09-05 Alza Corporation Temperature modulation of transdermal drug delivery
US20070260171A1 (en) 2005-09-27 2007-11-08 Higuchi John W Intraocular iontophoretic device and associated methods
WO2007050645A2 (en) * 2005-10-24 2007-05-03 Aciont, Inc. Intraocular iontophoretic device and associated methods
US8634907B2 (en) * 2005-10-24 2014-01-21 Aciont, Inc. Intraocular iontophoretic device and associated methods
US8099162B2 (en) 2005-11-29 2012-01-17 Eyegate Pharma, S.A.S. Ocular iontophoresis device
EP2319558B1 (en) 2006-03-14 2014-05-21 University Of Southern California Mems device for delivery of therapeutic agents
US20080214985A1 (en) * 2007-02-02 2008-09-04 Activatek, Inc. Active transdermal medicament patch
JP5542691B2 (ja) * 2007-12-20 2014-07-09 ユニバーシティ オブ サザン カリフォルニア 治療薬を送達するための装置および方法
US8231608B2 (en) 2008-05-08 2012-07-31 Minipumps, Llc Drug-delivery pumps and methods of manufacture
JP2014528793A (ja) 2011-09-19 2014-10-30 クラフト，ダニエル，エル． 点眼剤ディスペンサー
AU2013299785B2 (en) * 2012-08-06 2017-09-07 Baylor College Of Medicine Therapeutics dispensing device and methods of making same
US10105487B2 (en) 2013-01-24 2018-10-23 Chrono Therapeutics Inc. Optimized bio-synchronous bioactive agent delivery system
CN203389001U (zh) * 2013-05-30 2014-01-15 中山大学中山眼科中心 一种眼后段透巩膜控释给药装置
JP2017538728A (ja) 2014-12-19 2017-12-28 ケミン、インダストリーズ、インコーポレーテッドＫｅｍｉｎ Ｉｎｄｕｓｔｒｉｅｓ， Ｉｎｃ． イオントフォレシスを用いた生物活性分子の眼内送達
MX2017009193A (es) * 2015-01-22 2017-12-12 Eyegate Pharmaceuticals Inc Lente de contacto iontoforetica.
JP2020500081A (ja) 2016-09-28 2020-01-09 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． オピオイドを送達する経皮薬剤送達装置
EP3908238B1 (en) 2019-01-09 2026-03-25 Verily Life Sciences LLC Eye mounted device for therapeutic agent release

Similar Documents

Publication Publication Date Title
JP2022516945A5 (https=)
ES2290120T3 (es) Procedimientos para mejorar la dimension y el aspecto de una herida.
JP2009542657A5 (https=)
JP2010531298A5 (https=)
JP2015528501A5 (https=)
JP2022523530A5 (https=)
US20230093154A1 (en) Topical formulations and treatments
CN105168119A (zh) 一种治疗鼻炎的复方滴鼻用凝胶制剂
Cornwell et al. Hypersensitivity reactions to IV melphalan during treatment of multiple myeloma: Cancer and Leukemia Group B experience
JP6770091B2 (ja) ニコチン性アセチルコリン受容体アゴニストによる副鼻腔粘膜疾患を処置するための組成物及び方法
Grunberg et al. Chemotherapy-induced nausea and vomiting: contemporary approaches to optimal management: Proceedings from a symposium at the 2008 Multinational Association of Supportive Care in Cancer (MASCC) Annual Meeting
CN102228588A (zh) 治疗坐骨神经痛的外用中药组合物及其制备方法
JP2021535163A5 (https=)
CN114588164B (zh) 瑞马唑仑在预防围术期低体温和寒战中的应用
JP2000507207A (ja) 複合注射剤
WO2020031148A1 (en) Pharmaceutical composition, medicinal product and method of treatment of bronchopulmonary obstructive diseases
US12005068B2 (en) Formulation including doxycycline hyclate and method for administering the same
Margolis et al. Treatment of acute gouty arthritis with pituitary adrenocorticotropic hormone (ACTH)
RU2200557C1 (ru) Способ лечения гипертрофических и келоидных рубцов
JPH03236330A (ja) 炎症治療剤
JP2022543598A5 (https=)
JAyAkAr et al. Dexamethasone versus Clonidine as Adjuvants to Ropivacaine in Popliteal Sciatic Nerve Blocks for Postoperative Analgesia in Foot and Ankle Surgeries: A Randomised Clinical Study.
CN119868435B (zh) 治疗陈旧性踝关节扭伤的中药组合物和中药膏摩剂
RU2295349C2 (ru) Способ лечения остеоартроза коленных суставов с использованием внутрисуставного введения препарата "хондролон"
Ehrlich Treatment of rheumatoid arthritis